G1 Therapeutics and Boehringer Ingelheim Announce Co-Promotion Agreement for Trilaciclib in Small Cell Lung Cancer in the United States and Puerto Rico

Ads

You May Also Like

Aduro Biotech to Host Research and Development Day in New York

BERKELEY, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

NewLink Genetics Reports First Quarter 2017 Financial Results and Updates Clinical Trial Guidance

AMES, Iowa, May 04, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), today reported ...